Navigation Links
Saebo United Kingdom Posts Record 2008; Sees Continued Growth in UK for 2009
Date:4/16/2009

National Health Service hospitals' usage by stroke rehab patients dictates increase in staff and Saebo-trained therapists

CHARLOTTE, N.C., April 16 /PRNewswire/ -- Saebo, Inc. announced in its first quarter that its subsidiary, Saebo UK, Ltd., had another record year in 2008 and has added staff to accommodate its continued impressive growth in 2009.

"2008 was another record year for Saebo UK," said UK Managing Director, Glyn Blakey. "In the second half of 2008 alone, we trained an additional 80 physiotherapists and occupational therapists, bringing the total to over 250 Saebo-trained therapists throughout the United Kingdom. Additional trainers, administrative staff and technical support personnel were hired to keep up with our growth to ensure we continue to provide excellent service and support to patients."

"We were also successful in selling the Saebo In-Patient Treatment

Programme in 2008 to a number of leading National Health Service (NHS) hospitals. These hospitals have embraced Saebo's products and we continue to have good success selling the In-Patient Treatment Kit to NHS facilities so far in 2009," Blakey concluded.

Henry Hoffman, President of Saebo, Inc. added, "Saebo UK was a big contributor to our overall success in 2008. The UK team has done a great job of building the business and the Saebo brand throughout the UK. The traction we are now gaining with the NHS, combined with the increase in the number of Saebo-trained therapists bodes well for another great year for Saebo UK."

About Saebo UK, Ltd.

Based 25 minutes north of London, Saebo UK, Ltd. is a wholly-owned subsidiary of Saebo, Inc. With a network of over 250 Saebo-trained therapists throughout the UK, Saebo UK provides products and services to hundreds of patients per year. For more information or to find a Saebo-trained therapist in the United Kingdom, go to www.saebo.com, go to the "International" page and click on the "United Kingdom" to look under "UK Locations."

About Saebo, Inc.

Saebo, Inc. is a global provider of innovative rehabilitation products for stroke survivors and other neurologically impaired individuals. Headquartered in Charlotte, NC, the company was founded in 2001 by two occupational therapists specializing in stroke rehabilitation. Saebo's pioneering treatment protocols are based on new research documenting the brain's remarkable ability to "re-program" itself following injury. The company's neurological orthotic devices, SaeboFlex and SaeboReach, allow patients with very little residual hand function to forge new pathways in the brain to immediately begin grasping and releasing objects in high repetition exercises. Named Most Valuable Product in 2008 by Therapy Times, the SaeboFlex and SaeboReach are now offered at over 1,500 clinics and hospitals nationwide. Used within 22 of the "Top 25 Rehabilitation Hospitals" (U.S. News & World Report), Saebo products are eligible for reimbursement by Medicare and most commercial insurers. A network of over 3,400 trained clinicians, spanning four continents, is committed to helping stroke survivors around the globe achieve a new level of independence. www.saebo.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Henry Hoffman

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87812


'/>"/>
SOURCE Saebo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Saebo Expands Internet Presence With Launch of New Website
2. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
3. United States continues to have highest level of health spending
4. United Medicorp, Inc.s Shareholders Approve All Proposals
5. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
6. Medical Services International Received Its First Order for Testing By Regulatory Agencies in the United States
7. Peoples United Financial CEO Has Surgery
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. More Than 100 Organizations Call for a National AIDS Strategy to End the Epidemic in the United States
10. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
11. Universal Health Care Coverage in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... VA (PRWEB) , ... January 18, 2017 , ... Floundering ... American Heart Month and the perfect time for a reset. The U.S. Apple Association ... studies to combat many of the factors that contribute to heart disease. , The ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... a point of difference. Eden Activewear is a stand-out company for several differences ... exclusively online and only manufacture on demand, this is called 'Agile' manufacturing - ...
(Date:1/17/2017)... ... January 17, 2017 , ... SunView Software’s Service Smart ... Innovation of the Year. , Each year, Pink Elephant recognizes a new ... approach to address a specific business problem or opportunity. The award highlights original innovations ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... Palm Desert, is opening a new office in San Clemente, California this month. ... (dTMS) in Southern California, successfully treating individuals struggling with major depression. Depression impacts ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... SightMD – will lecture to primary eye care practitioners on the latest breakthroughs ... the upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017 In China , we ... the Upgrade of China,s Healthy Strategy ... Plan for Economic and Social Development of the ... and the state council of the People,s Republic ... emerging industry development plan, identifying medical devices as one of ...
(Date:1/18/2017)... Invetech, the leading developer of ... , has announced a collaboration agreement with Erytech ... treatments for acute leukemia and other oncology indications ... will develop systems to enable the commercial-scale manufacture ... platform, which uses a novel technology to encapsulate ...
(Date:1/18/2017)... Mass. , Jan. 18, 2017  Tarix Orphan ... Administration has granted a Rare Pediatric Disease (RPD) designation ... of Recessive Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic ... RDEB and treatment is limited to supportive care. ... the Orphan Drug Designation previously granted by the FDA ...
Breaking Medicine Technology: